Monkeypox in a Traveler Returning from Nigeria — Dallas, Texas, July 2021Agam K. Rao, Theodora Khan, Matthew J. Arduino et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 277
Severe Monkeypox in Hospitalized Patients — United States, August 10–October 10, 2022Maureen J. Miller, Hillary Spencer, Shama Cash‐Goldwasser et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 204
Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022Kevin O’Laughlin, Max Veillard, Farrell A. Tobolowsky et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 139
Safety and Improved Clinical Outcomes in Patients Treated With New Equine-Derived Heptavalent Botulinum AntitoxinPatricia Yu, Agam K. Rao, Neal H. Lin et al.|Clinical Infectious Diseases|2017Cited by 98
<i>Orthopoxvirus</i> Testing Challenges for Persons in Populations at Low Risk or Without Known Epidemiologic Link to Monkeypox — United States, 2022Faisal S. Minhaj, Sapna Bamrah Morris, Julia K. Petras et al.|MMWR Morbidity and Mortality Weekly Report|2022Cited by 42